Endometriosis Forecast in 9 Major Markets 2015-2025
|出版商||Black Swan Analysis||商品編碼||339881|
|出版日期||內容資訊||英文 36 Pages
|子宮內膜異位症:主要9個國家的市場預測 Endometriosis Forecast in 9 Major Markets 2015-2025|
|出版日期: 2015年09月01日||內容資訊: 英文 36 Pages||
子宮內膜異位症是在子宮外側發現一般生長在子宮 (子宮內膜) 內側的細胞之婦科疾病。這是會引起嚴重的月經、下腹部疼痛，以及不孕問題的慢性疾病。
本報告提供全球主要9個國家(美國，法國，德國，義大利，西班牙，英國，巴西，日本，印度) 的子宮內膜異位症發病情形相關分析，提供您疾病概要和目前的患病人數，性別·各年代 (以五歲為區分) 的詳細情況，各地區·各民族趨勢，風險要素，疾病診斷與預後，主要的症狀和併發症，未來性的趨勢預測 (今後10年份) 等資訊，為您概述為以下內容。
Endometriosis is a gynaecological condition where tissue that normally behaves like the lining of the womb (endometrium) is found outside the womb. These pieces of tissue are commonly found on the ovaries and the lining of the pelvis behind the uterus. This is a chronic condition that causes heavy periods, lower abdominal pain and can cause fertility issues. This report provides the current prevalent population for Endometriosis across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the types, occlusion locations and the prevalence of associated disorders of Endometriosis. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Endometriosis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Endometriosis include:
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.